A synthetic chimeric gene, TBI-HBS, encoding the immunogenic ENV and GAG epitopes of human immunodeficiency virus (HIV-1) and the surface protein antigen (HBsAg) of hepatitis B virus (HBV), was expressed in tomato plants. Tomato fruits containing the TBI-HBS antigen were fed to experimental mice and, on days 14 and 28 post-feeding, high levels of HIV- and HBV-specific antibodies were present in the serum and feces of the test animals. Intraperitoneal injection of a DNA vaccine directing synthesis of the same TBI-HBsAg antigen boosted the antibody response to HIV in the blood serum; however, it had no effect on the high level of antibodies produced to HBV. © Springer Science+Business Media B.V. 2006.
CITATION STYLE
Shchelkunov, S. N., Salyaev, R. K., Pozdnyakov, S. G., Rekoslavskaya, N. I., Nesterov, A. E., Ryzhova, T. S., … Hammond, R. W. (2006). Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnology Letters, 28(13), 959–967. https://doi.org/10.1007/s10529-006-9028-4
Mendeley helps you to discover research relevant for your work.